Npt2a as a target for treating hyperphosphatemia
Sign Up to like & getrecommendations! Published in 2022 at "Biochemical Society Transactions"
DOI: 10.1042/bst20211005
Abstract: Hyperphosphatemia results from an imbalance in phosphate (Pi) homeostasis. In patients with and without reduced kidney function, hyperphosphatemia is associated with cardiovascular complications. The current mainstays in the management of hyperphosphatemia are oral Pi binder… read more here.
Keywords: kidney; hyperphosphatemia; npt2a target; target treating ... See more keywords